Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy

Epilepsia

Volumn 41, Issue 12, 2000, Pages 1514-1521

  Postma, T ^a   Krupp, E ^a   Li, X L ^a   Post, R M ^a   Weiss, S R B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amygdala; Epilepsy; Kindling; Lamotrigine; Rats

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPILEPSY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

AMYGDALA; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TRIAZINES;

EID: 0034533008     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Antiepileptic drugs in development: Prospects for the near future
2. Clinical experience with new antiepileptic drugs: Antiepileptic drugs in Europe
3. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction
4. Sudden death in two patients with epilepsy and the syndrome of inappropriate antidiuretic hormone secretion (SIADH)
5. Pharmacological management of epilepsy: Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities
6. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures
7. Lamotrigine: Clinical experience in 200 patients with epilepsy with follow-up to four years
8. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder
9. Clinical studies on the use of lamotrigine in bipolar disorder
10. Beyond lithium in the treatment of bipolar illness
11. Alternative approaches to refractory depression in bipolar illness
12. Neurochemical and behavioral aspects of lamotrigine
13. Lamotrigine
14. Effect of carbamazepine, oxycarbamazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum
15. Voltage-activated calcium channels: Targets of antiepileptic drug therapy?
16. Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: Implications for neuroprotective strategies
17. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
18. ++ influx in dissociated amygdala neurons
19. A permanent change in brain function resulting from daily electrical stimulation
20. Progressive neuronal loss induced by kindling: A possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis
21. Mossy fiber synaptic reorganization induced by kindling: Time course of development, progression, and permanence
22. Synaptic reorganization in the hippocampus induced by abnormal functional activity
23. Long-term structural and functional alterations induced in the hippocampus by kindling: Implications for memory dysfunction and the development of epilepsy
24. Morphometric effects of intermittent kindled seizures and limbic status epilepticus in the dentate gyrus of the rat
25. The hippocampus in experimental chronic epilepsy: A morphometric analysis
26. Neuronal growth and neuronal loss in kindling epileptogenesis
27. Spontaneous kindled motor seizures in rats
28. Persistent seizure susceptibility and recurrent spontaneous seizures in kindled cats
29. Does the engram of kindling model the engram of normal long term memory?
30. Sensitization and kindling: Implications for the evolution of psychiatric symptomatology
31. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations
32. Kindling: Separate versus shared mechanisms in affective disorders and epilepsy
33. Kindling: Implications for the course of treatment of affective disorders
34. Sensitization and kindling: Implications for the evolving neural substrates of PTSD
35. Carbamazepine and carbamazepine-10, 11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development
36. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy
37. A study of the action of valproic acid on the kindling effect
38. Effects of diazepam and diphenylhydantoin on elicited and spontaneous seizures in kindled rats: A double dissociation
39. Kindling as a model of drug-resistant partial epilepsy: Selection of phenytoin-resistant and nonresistant rats
40. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin
41. Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats
42. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: Cross-tolerance to carbamazepine but not valproate or diazepam
43. The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats
44. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats
45. Lamotrigine versus phenytoin for treatment of status epilepticus: Comparison in an experimental model
46. Modification of seizure activity by electrical stimulation. II. Motor seizure
47. Effects of various antiepileptic drugs on plasma levels of lamotrigine, an novel antiepileptic, in rats
48. Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine
49. Carbamazepine pharmacokinetics in young, adult and pregnant rats: Relation to pharmacological effects
50. Prophylactic antiepileptic agents after head injury: A systematic review
51. Causes, prevention, and treatment of post-traumatic epilepsy
52. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures
53. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat
54. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models
55. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy
56. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP
57. Increase of kainate receptor mRNA in the hippocampal CA3 of amygdalakindled rats detected by in situ hybridization
58. A new pyrrolylquinoxalinedione series of non-NMDA glutamate receptor antagonists: Pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy
59. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: Pharmacological characterization and comparison with NBQX and L-701, 324 in the kindling model of epilepsy
60. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells
61. Lamotrigine: An update of its pharmacology and therapeutic use in epilepsy
62. + channels
63. Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes
64. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
65. 3H]batrachotoxinin A 20-α-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine
66. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells
67. NMDA receptors: Their role in long-term potentiation
68. Contributions of quisqualate and NMDA receptors to the induction and expression of LTP
69. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning
70. Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning
71. Stimulant-induced behavioral sensitization: A model for neuroleptic nonresponsiveness
72. Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression